لماذا يرتفع سعر سهم INTUITIVE SURGICAL؟
المتفائلون يقولون
System placements
Analyst highlights that stronger-than-expected system placements boosted revenue and indicate robust demand for Intuitive Surgical's robotic platforms, supporting continued installed-base expansion and procedure adoption.
Profitability and margins
Analyst reports that gross and operating margins came in above expectations, reflecting improving operational efficiency that can support earnings even if procedure growth moderates.
Total addressable market
Analyst emphasizes a large market opportunity across gastrointestinal and other specialties, noting that expanded screening and a growing pool of surgically trained physicians could drive long-term robotic procedure growth.
Instrument program impact
Analyst warns that extended-use instrument programs will lower revenue per procedure and create near-term headwinds to procedure-related product and service revenue despite potential longer-term benefits.
Procedure growth and guidance
Analyst points out that U.S. procedure growth has slowed from elevated expectations and that tightened procedure guidance increases uncertainty, which can weigh on near-term stock performance.
Competition and alternative therapies
Analyst notes rising competitive intensity and the impact of new weight-loss drugs on bariatric volumes could narrow Intuitive Surgical's valuation premium and constrain growth in key segments.
